Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$6.69 - $11.0 $3,191 - $5,247
-477 Reduced 38.97%
747 $6,000
Q4 2023

Feb 13, 2024

SELL
$7.85 - $11.78 $3,273 - $4,912
-417 Reduced 25.41%
1,224 $10,000
Q3 2023

Nov 14, 2023

SELL
$12.89 - $16.29 $8,223 - $10,393
-638 Reduced 27.99%
1,641 $21,000
Q2 2023

Aug 21, 2023

BUY
$12.62 - $18.4 $28,760 - $41,933
2,279 New
2,279 $36,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $68.8M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.